Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

2802.T JP Equity

Ajinomoto Co., Inc.Consumer Staples · FY ends Mar 31
JPY 5,535.00
-186.00 (-3.25%)
JPY · as of 2026-08-18 · marketstack
4 registered studies · 0 active

Studies where 2802.T is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.

3 interventional · 1 observational

Held by 0 tracked-famous managers · government filings 180d: none disclosed

StudyPhaseStatusInterventionsConditionsEnrollmentPrimary completionUpdated
Evaluation of Low Phenylalanine FormulasNCT06332105Change in blood Phe inRandomized · Open-label · TreatmentNot applicableUnknown statusDietary supplement: Glytactin, L-AAPhenylketonurias19Jan 20252024-04-15
Biomarkers for Gynecologic CancerNCT02178462observationalPerformance characteristics of AminoIndexTM biomarker to discriminate gynecologic cancer from benign disease or healthy subjectsUnknown statusOvarian Cancer, Endometrial Cancer, Benign Gynecological Disease153Mar 20182018-01-31
Monosodium L-glutamate (MSG) on SatietyNCT02446106The difference in total energy intake (lunch and snack) compared with a control, as determined by food amount that subject consumed using a food scale (weigh foods before and after).Randomized · Single-masked · Basic scienceNot applicableCompletedDietary supplement: Soup with MSG, Control soup no MSGNutrition Intervention75Sep 2012actual2015-05-18
Effect of Monosodium L-Glutamate (MSG) and Nucleic Acid (IMP) on Satiety and Food IntakeNCT01761045Differences in food intake and subjective satiety motivational responses to treatmentsRandomized · Quadruple-masked · Basic scienceNot applicableCompletedDietary supplement: Soup 1, Soup 2, Soup 3Nutrition Intervention80Jan 2011actual2013-02-11

Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.

Source: ClinicalTrials.gov, retrieved 2026-08-19